Medical abortions using misoprostol with or without mifepristone are no more likely than surgical abortions to increase the risk of spontaneous abortion, ectopic pregnancy, preterm birth, or low birthweight in subsequent pregnancies, researchers report in the Aug. 16 issue of the New England Journal of Medicine.
Medical abortions using misoprostol with or without mifepristone are no more likely than surgical abortions to increase the risk of spontaneous abortion, ectopic pregnancy, preterm birth, or low birthweight in subsequent pregnancies, researchers report in the Aug. 16 issue of the New England Journal of Medicine.
Jasveer Virk, MS, MPH, of the University of California Los Angeles, and colleagues conducted a cohort study of 11,814 Danish women who had undergone a first-trimester abortion followed by at least one subsequent pregnancy. Researchers compared the risks of pregnancy complications in women who underwent medical abortion compared to those who had a surgical abortion.
Overall, 2,710 women had medical abortions and 9,104 had surgical abortions. After controlling for maternal age, interval between pregnancies, and other demographic factors, medical abortion was not associated with an increased risk compared to surgical abortion in any of the variables evaluated (ectopic pregnancy, spontaneous abortion, preterm birth or low birthweight).
Virk J, Zhang J, Olsen J. Medical abortion and the risk of subsequent adverse pregnancy outcomes. N Engl J Med. 2007;357:648-653.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More